| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046675474 |
| P356 | DOI | 10.1023/A:1026448026716 |
| P698 | PubMed publication ID | 10390143 |
| P50 | author | Maria Mercedes Binda | Q43190498 |
| R. Daniel Bonfil | Q67488266 | ||
| P2093 | author name string | O G Scharovsky | |
| V R Rozados | |||
| E A Roggero | |||
| P Matar | |||
| P2860 | cites work | Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth | Q28323559 |
| Delivery of novel therapeutic agents in tumors: physiological barriers and strategies | Q38615180 | ||
| Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia | Q39993005 | ||
| Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma | Q41358164 | ||
| Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines | Q41519199 | ||
| Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). | Q41873469 | ||
| Transplantable osteosarcomas with high lung metastatic potential in Fischer 344 rats | Q44791297 | ||
| Proceedings: Tumor angiogenesis factor | Q47852764 | ||
| The effect of AGM-1470 in an improved intracranial 9L gliosarcoma rat model | Q48151826 | ||
| Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470. | Q55479722 | ||
| Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent | Q67682540 | ||
| Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease | Q67900636 | ||
| Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor vasculature | Q68468194 | ||
| Tumor angiogenesis | Q69383199 | ||
| Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas | Q70487680 | ||
| Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470 | Q70560719 | ||
| Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma | Q70819720 | ||
| Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected | Q71102407 | ||
| Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice | Q71649319 | ||
| Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression | Q71802927 | ||
| Correlation of high lactate levels in human cervical cancer with incidence of metastasis | Q71804653 | ||
| Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes | Q71862717 | ||
| Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470) | Q72093753 | ||
| Efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (AGM-1470) on osteosarcoma growth and lung metastasis in rats | Q72225778 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 19-25 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Clinical & Experimental Metastasis | Q13470030 |
| P1476 | title | Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma | |
| P478 | volume | 17 |
| Q43162316 | Antiangiogenic mechanisms of simvastatin in retinal endothelial cells |
| Q35069176 | Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database |
| Q34164712 | Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells |
| Q40660052 | Effect of phytosterols on cholesterol metabolism and MAP kinase in MDA-MB-231 human breast cancer cells |
| Q33871661 | Exploiting the critical perioperative period to improve long-term cancer outcomes |
| Q34605246 | HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis |
| Q37239002 | Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina |
| Q37490519 | Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin |
| Q36002780 | Lipid-lowering drugs |
| Q44197472 | Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells. |
| Q40841557 | Lovastatin and simvastatin are modulators of the proteasome. |
| Q33588228 | Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression |
| Q44062588 | Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism |
| Q41080847 | Marketed drugs used for the management of hypercholesterolemia as anticancer armament |
| Q38358594 | Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells |
| Q36906404 | Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. |
| Q37415623 | Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas. |
| Q87527196 | Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy |
| Q37538571 | Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis |
| Q35602162 | Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies |
| Q35153749 | The lipid and non-lipid effects of statins |
| Q36024705 | Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies |
Search more.